DIADEMA PARTNERS LP
Filing Date
Global Rank
#2,150
/ 8,232
▲ 255
Top Industry
Biotechnology
78.0%
3Y Alpha vs SPY
-4.7%
Period ended 2 months ago
Filed May 15, 2026 · 30d
6 quarters · since Dec 2024
Clone Performance
Feb 2025–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+16.9%
SPY
+23.4%
Annualised alpha
-4.7%
Max drawdown
−19.0%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
109 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
9.1%
+0.1 pts
Top 5
34.5%
+0.5 pts
Top 10
52.1%
+1.2 pts
HHI
371
Diversified+15
Portfolio Trend
6 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $567,677,067 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| LQDA | Liquidia Corp | +690,219 | 712,100 | $26,874,654 | |
| REPL | Replimune Group, Inc. | +535,063 | 766,060 | $5,860,359 | |
| KOD | Kodiak Sciences Inc. | +410,462 | 440,062 | $16,775,163 | |
| CAPR | Capricor Therapeutics, Inc. | +361,176 | 1,031,551 | $31,359,150 | |
| AVXL | Anavex Life Sciences Corp. | +337,000 | 477,600 | $1,466,232 | |
| CRVS | Corvus Pharmaceuticals, Inc. | +298,011 | 351,111 | $5,136,753 | |
| QURE | uniQure N.V. | +233,400 | 580,200 | $9,486,270 | |
| ABVX | Abivax S.A. | +200,300 | 275,944 | $30,726,364 | |
| COGT | Cogent Biosciences, Inc. | +190,912 | 322,764 | $12,423,186 | |
| EWTX | Edgewise Therapeutics, Inc. | +182,500 | 212,500 | $6,693,750 | |
| RVMD | Revolution Medicines, Inc. | +169,352 | 206,372 | $20,069,677 | |
| GLUE | Monte Rosa Therapeutics, Inc. | +125,026 | 187,307 | $3,081,200 | |
| IMCR | Immunocore Holdings plc | +122,889 | 193,189 | $5,824,648 | |
| BHVN | Biohaven Ltd. | +117,000 | 317,000 | $2,681,820 | |
| EQ | Equillium, Inc. | +86,451 | 433,844 | $867,688 | |
| HRMY | Harmony Biosciences Holdings, Inc. | +85,364 | 92,864 | $2,601,120 | |
| INCY | Incyte Corp | +83,429 | 183,429 | $17,264,337 | |
| UTHR | UNITED THERAPEUTICS Corp | +77,503 | 87,503 | $51,887,528 | |
| PCVX | Vaxcyte, Inc. | +55,199 | 78,171 | $4,542,516 | |
| FHTX | Foghorn Therapeutics Inc. | +49,314 | 79,944 | $382,132 | |
| AYTU | Aytu Biopharma, Inc | +47,289 | 353,077 | $963,900 | |
| IVA | Inventiva S.A. | +18,148 | 352,399 | $1,955,814 | |
| NVO | Novo Nordisk A S | +17,377 | 70,477 | $2,590,029 | |
| ROIV | Roivant Sciences Ltd. | +17,100 | 335,800 | $9,301,660 | |
| TLPH | Talphera, Inc. | +16,640 | 153,563 | $115,172 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| MNKD | Mannkind Corp | −667,697 | 186,603 | $457,177 | |
| NTLA | Intellia Therapeutics, Inc. | −329,300 | 200,000 | $2,564,000 | |
| BBIO | BridgeBio Pharma, Inc. | −324,289 | 85,311 | $6,335,194 | |
| BIOA | BioAge Labs, Inc. | −233,764 | 60,000 | $1,049,400 | |
| TERN | Terns Pharmaceuticals, Inc. | −228,828 | 181,752 | $9,581,965 | |
| LPCN | Lipocine Inc. | −210,939 | 50,000 | $399,500 | |
| RLMD | Relmada Therapeutics, Inc. | −188,553 | 200,842 | $1,397,860 | |
| ANNX | Annexon, Inc. | −172,984 | 486,116 | $2,693,082 | |
| VKTX | Viking Therapeutics, Inc. | −158,068 | 1,184,381 | $38,539,757 | |
| SLS | SELLAS Life Sciences Group, Inc. | −124,900 | 300,000 | $1,269,000 | |
| ZYME | Zymeworks Inc. | −119,868 | 142,132 | $3,558,985 | |
| VTGN | Vistagen Therapeutics, Inc. | −101,072 | 105,428 | $60,093 | |
| VIR | Vir Biotechnology, Inc. | −100,400 | 88,800 | $795,648 | |
| TRVI | Trevi Therapeutics, Inc. | −75,521 | 21,663 | $258,439 | |
| RARE | Ultragenyx Pharmaceutical Inc. | −64,856 | 35,144 | $736,266 | |
| CORT | Corcept Therapeutics Inc | −63,745 | 168,500 | $6,792,235 | |
| TENX | Tenax Therapeutics, Inc. | −63,432 | 179,738 | $2,874,010 | |
| JNJ | Johnson & Johnson | −62,673 | 53,771 | $13,143,783 | |
| JAZZ | Jazz Pharmaceuticals plc | −50,545 | 54,755 | $10,351,432 | |
| XERS | Xeris Biopharma Holdings, Inc. | −37,822 | 132,746 | $769,926 | |
| TGTX | Tg Therapeutics, Inc. | −16,355 | 206,928 | $6,874,148 | |
| OLMA | Olema Pharmaceuticals, Inc. | −12,100 | 84,000 | $1,252,440 | |
| CRSP | CRISPR Therapeutics AG | −6,400 | 106,300 | $5,056,691 | |
| ATYR | aTYR PHARMA INC | −2,600 | 24,700 | $19,266 | |
| VRTX | Vertex Pharmaceuticals Inc / Ma | −1,360 | 96,940 | $43,287,587 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
25 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| CYTK | Cytokinetics Inc | 250,000 | $16,477,500 | |
| MRK | Merck & Co., Inc. | 100,000 | $12,029,000 | |
| MRNA | Moderna, Inc. | 159,400 | $8,097,520 | |
| ABBV | AbbVie Inc. | 24,058 | $5,232,374 | |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | 555,257 | $5,213,863 | |
| RCUS | Arcus Biosciences, Inc. | 238,142 | $5,143,867 | |
| EYPT | EyePoint, Inc. | 284,845 | $3,671,652 | |
| ALMS | Alumis Inc. | 131,200 | $2,890,336 | |
| CELC | Celcuity Inc. | 23,014 | $2,626,817 | |
| VYGR | Voyager Therapeutics, Inc. | 573,642 | $2,214,258 | |
| BCYC | Bicycle Therapeutics PLC | 476,424 | $2,210,607 | |
| INDV | Indivior Pharmaceuticals, Inc. | 71,376 | $2,175,540 | |
| CLYM | Climb Bio, Inc. | 286,126 | $1,959,963 | |
| TARS | Tarsus Pharmaceuticals, Inc. | 25,942 | $1,819,831 | |
| ALKS | Alkermes plc. | 50,000 | $1,768,000 | |
| MGNX | Macrogenics Inc | 600,000 | $1,734,000 | |
| CTMX | CytomX Therapeutics, Inc. | 316,000 | $1,485,200 | |
| KPTI | Karyopharm Therapeutics Inc. | 241,300 | $1,344,041 | |
| IOVA | Iovance Biotherapeutics, Inc. | 302,900 | $1,063,179 | |
| OCGN | Ocugen, Inc. | 500,000 | $905,000 | |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | 10,000 | $839,200 | |
| PHVS | Pharvaris N.V. | 29,321 | $828,318 | |
| IBRX | ImmunityBio, Inc. | 106,300 | $815,321 | |
| LRMR | Larimar Therapeutics, Inc. | 166,637 | $749,866 | |
| UNCY | Unicycive Therapeutics, Inc. | 106,083 | $698,026 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
25 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| PRAX | Praxis Precision Medicines, Inc. | 100,600 | $29,650,844 | |
| QQQ | Invesco Qqq Trust, Series 1 | 30,000 | $18,429,300 | |
| REGN | Regeneron Pharmaceuticals, Inc. | 15,300 | $11,809,611 | |
| INSM | INSMED Inc | 52,800 | $9,189,312 | |
| IONS | Ionis Pharmaceuticals Inc | 106,200 | $8,401,482 | |
| OCUL | Ocular Therapeutix, Inc | 545,200 | $6,618,728 | |
| ANIP | Ani Pharmaceuticals Inc | 53,354 | $4,211,764 | |
| SLNO | Soleno Therapeutics Inc | 79,992 | $3,703,629 | |
| AQST | Aquestive Therapeutics, Inc. | 548,800 | $3,545,248 | |
| RXRX | Recursion Pharmaceuticals, Inc. | 741,900 | $3,034,371 | |
| RVPH | Reviva Pharmaceuticals Holdings, Inc. | 500,000 | $2,800,000 | |
| CNTA | Centessa Pharmaceuticals plc | 111,100 | $2,778,611 | |
| GOSS | Gossamer Bio, Inc. | 877,100 | $2,719,010 | |
| ABUS | Arbutus Biopharma Corp | 548,600 | $2,638,766 | |
| IRWD | Ironwood Pharmaceuticals Inc | 683,611 | $2,303,769 | |
| ONC | BeOne Medicines Ltd. | 7,500 | $2,278,575 | |
| ALNY | Alnylam Pharmaceuticals, Inc. | 5,341 | $2,123,848 | |
| TECX | Tectonic Therapeutic, Inc. | 100,600 | $2,098,516 | |
| PTGX | Protagonist Therapeutics, Inc | 22,700 | $1,982,618 | |
| TVTX | Travere Therapeutics, Inc. | 50,300 | $1,921,963 | |
| ALT | Altimmune, Inc. | 491,800 | $1,775,398 | |
| VNDA | Vanda Pharmaceuticals Inc. | 200,000 | $1,764,000 | |
| LEGN | Legend Biotech Corp | 69,000 | $1,500,060 | |
| BCRX | Biocryst Pharmaceuticals Inc | 190,928 | $1,489,238 | |
| ARDX | Ardelyx, Inc. | 252,198 | $1,470,314 | |
| No positions match the current search. | ||||
109 positions ·
$567,677,067 total
· as of Mar 31, 2026
Showing 1–50
of 109 positions by value
· page 1 of 3
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
Added | 87,503 | $51,887,528 | 9.14% | |
| VRTX |
Vertex Pharmaceuticals Inc / Ma
Healthcare
|
Reduced | 96,940 | $43,287,587 | 7.63% | |
| VKTX |
Viking Therapeutics, Inc.
Healthcare
|
Reduced | 1,184,381 | $38,539,757 | 6.79% | |
| CAPR |
Capricor Therapeutics, Inc.
Healthcare
|
Added | 1,031,551 | $31,359,150 | 5.52% | |
| ABVX |
Abivax S.A.
Healthcare
|
Added | 275,944 | $30,726,364 | 5.41% | |
| LQDA |
Liquidia Corp
Healthcare
|
Added | 712,100 | $26,874,654 | 4.73% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Added | 206,372 | $20,069,677 | 3.54% | |
| APGE |
Apogee Therapeutics, Inc.
Healthcare
|
Added | 222,500 | $18,727,825 | 3.30% | |
| INCY |
Incyte Corp
Healthcare
|
Added | 183,429 | $17,264,337 | 3.04% | |
| KOD |
Kodiak Sciences Inc.
Healthcare
|
Added | 440,062 | $16,775,163 | 2.96% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
NEW | 250,000 | $16,477,500 | 2.90% | |
| JNJ |
Johnson & Johnson
Healthcare
|
Reduced | 53,771 | $13,143,783 | 2.32% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
Added | 322,764 | $12,423,186 | 2.19% | |
| MRK |
Merck & Co., Inc.
Healthcare
|
NEW | 100,000 | $12,029,000 | 2.12% | |
| JAZZ |
Jazz Pharmaceuticals plc
Healthcare
|
Reduced | 54,755 | $10,351,432 | 1.82% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
Added | 199,734 | $9,627,178 | 1.70% | |
| TERN |
Terns Pharmaceuticals, Inc.
Healthcare
|
Reduced | 181,752 | $9,581,965 | 1.69% | |
| QURE |
uniQure N.V.
Healthcare
|
Added | 580,200 | $9,486,270 | 1.67% | |
| ROIV |
Roivant Sciences Ltd.
Healthcare
|
Added | 335,800 | $9,301,660 | 1.64% | |
| BMRN |
Biomarin Pharmaceutical Inc
Healthcare
|
Added | 148,229 | $8,373,456 | 1.48% | |
| MRNA |
Moderna, Inc.
Healthcare
|
NEW | 159,400 | $8,097,520 | 1.43% | |
| TGTX |
Tg Therapeutics, Inc.
Healthcare
|
Reduced | 206,928 | $6,874,148 | 1.21% | |
| CORT |
Corcept Therapeutics Inc
Healthcare
|
Reduced | 168,500 | $6,792,235 | 1.20% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
Added | 212,500 | $6,693,750 | 1.18% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
Reduced | 85,311 | $6,335,194 | 1.12% | |
| REPL |
Replimune Group, Inc.
Healthcare
|
Added | 766,060 | $5,860,359 | 1.03% | |
| IMCR |
Immunocore Holdings plc
Healthcare
|
Added | 193,189 | $5,824,648 | 1.03% | |
| LLY |
ELI LILLY & Co
Healthcare
|
Added | 6,000 | $5,518,620 | 0.97% | |
| ABBV |
AbbVie Inc.
Healthcare
|
NEW | 24,058 | $5,232,374 | 0.92% | |
| CRBP |
Corbus Pharmaceuticals Holdings, Inc.
Healthcare
|
NEW | 555,257 | $5,213,863 | 0.92% | |
| RCUS |
Arcus Biosciences, Inc.
Healthcare
|
NEW | 238,142 | $5,143,867 | 0.91% | |
| CRVS |
Corvus Pharmaceuticals, Inc.
Healthcare
|
Added | 351,111 | $5,136,753 | 0.90% | |
| CRSP |
CRISPR Therapeutics AG
Healthcare
|
Reduced | 106,300 | $5,056,691 | 0.89% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
Added | 78,171 | $4,542,516 | 0.80% | |
| EYPT |
EyePoint, Inc.
Healthcare
|
NEW | 284,845 | $3,671,652 | 0.65% | |
| ZYME |
Zymeworks Inc.
Healthcare
|
Reduced | 142,132 | $3,558,985 | 0.63% | |
| GLUE |
Monte Rosa Therapeutics, Inc.
Healthcare
|
Added | 187,307 | $3,081,200 | 0.54% | |
| ALMS |
Alumis Inc.
Healthcare
|
NEW | 131,200 | $2,890,336 | 0.51% | |
| TENX |
Tenax Therapeutics, Inc.
Healthcare
|
Reduced | 179,738 | $2,874,010 | 0.51% | |
| ANNX |
Annexon, Inc.
Healthcare
|
Reduced | 486,116 | $2,693,082 | 0.47% | |
| BHVN |
Biohaven Ltd.
Healthcare
|
Added | 317,000 | $2,681,820 | 0.47% | |
| CELC |
Celcuity Inc.
Healthcare
|
NEW | 23,014 | $2,626,817 | 0.46% | |
| HRMY |
Harmony Biosciences Holdings, Inc.
Healthcare
|
Added | 92,864 | $2,601,120 | 0.46% | |
| NVO |
Novo Nordisk A S
Healthcare
|
Added | 70,477 | $2,590,029 | 0.46% | |
| NTLA |
Intellia Therapeutics, Inc.
Healthcare
|
Reduced | 200,000 | $2,564,000 | 0.45% | |
| VYGR |
Voyager Therapeutics, Inc.
Healthcare
|
NEW | 573,642 | $2,214,258 | 0.39% | |
| BCYC |
Bicycle Therapeutics PLC
Healthcare
|
NEW | 476,424 | $2,210,607 | 0.39% | |
| INDV |
Indivior Pharmaceuticals, Inc.
Healthcare
|
NEW | 71,376 | $2,175,540 | 0.38% | |
| CLYM |
Climb Bio, Inc.
Healthcare
|
NEW | 286,126 | $1,959,963 | 0.35% | |
| IVA |
Inventiva S.A.
Healthcare
|
Added | 352,399 | $1,955,814 | 0.34% |